Release Date: 01/04/16 08:21 Summary: Six Months Financial Report ended 31 December 2015 Price Sensitive: No Download Document 833.06KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%